Drugs · Brain health technique
Lipid-Lowering Drugs
Evidence grade: Context Dependent

Therapies that reduce LDL cholesterol and vascular inflammation, including statins (atorvastatin, rosuvastatin, simvastatin), PCSK9 inhibitors (alirocumab, evolocumab), and ezetimibe (Zetia®). Used to prevent atherosclerosis and support cerebral blood flow.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Metabolic & Vascular Optimization Drugs
- Health domains
- vascular
- Evidence grade
- Context Dependent
- Strength of evidence
- Medium
- Cost
- High
- Effort
- Low
- Time commitment
- Low
How to practice Lipid-Lowering Drugs
Lipid screening should begin as early as possible. Measure ApoB and lp(a) at minimum, and targets should be based on overall risk and presence of existing disease. If levels are far from target and nutritional strategies have not meaningfully helped, consider treatment. Optimal lipid lowering strategy depends on your blood biomarkers, insurance coverage, budget, and risk tolerance.
The evidence behind Lipid-Lowering Drugs
High LDL cholesterol and blood vessel inflammation speed up atherosclerosis and small-vessel disease. Trials show statins and PCSK9 inhibitors, two types of LDL-lowering drugs, cut heart attacks and strokes. These drugs help your vessel lining work better, boost nitric oxide, and stabilize plaque. Evidence for this blood vessel protection is strong.
Impact on brain health
High LDL and blood vessel inflammation also raise dementia risk, and these drugs' effects on your vessels help keep blood flowing to your brain. Studies that follow treated individuals over time suggest a lower dementia risk, especially with long-term use. The evidence for direct brain protection is moderate, and weaker than for your heart and blood vessels.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.